{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:21:33Z","timestamp":1790432493571,"version":"4.1.0"},"reference-count":369,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00108","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T04:51:31Z","timestamp":1582606291000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":83,"title":["Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action"],"prefix":"10.3389","volume":"11","author":[{"given":"Bruno P.","family":"Meloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"Mastaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville W.","family":"Knuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nbt0398-286","article-title":"Selected peptides targeted to the NMDA receptor channel protect neurons from excitotoxic death","volume":"16","author":"Ferrer-Montiel","year":"1998","journal-title":"Nat Biotechnol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0014-5793(00)01982-7","article-title":"Arginine-rich peptides are blockers of VR-1 channels with analgesic activity","volume":"481","author":"Planells-Cases","year":"2000","journal-title":"FEBS Lett."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1089\/ars.2009.2445","article-title":"Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity","volume":"11","author":"Yang","year":"2009","journal-title":"Antioxid Redox Signal."},{"key":"B4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3233\/JAD-2010-100564","article-title":"Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons","volume":"20","author":"Manczak","year":"2010","journal-title":"J Alzheimers Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/cns.12326","article-title":"Targeting CD36-mediated inflammation reduces acute brain injury in transient but not permanent ischemic stroke","volume":"21","author":"Kim","year":"2015","journal-title":"CNS Neurosci Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1159\/000484919","article-title":"Mitochondria targeted peptide attenuates mitochondrial dysfunction controls inflammation and protects against spinal cord injury-induced lung injury","volume":"44","author":"Zhu","year":"2017","journal-title":"Cell Physiol Biochem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1021\/acschemneuro.8b00013","article-title":"Protective effect of a mitochondria-targeted peptide against the development of chemotherapy-induced peripheral neuropathy in mice","volume":"9","author":"Toyama","year":"2018","journal-title":"ACS Chem Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/1073858407309762","article-title":"Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences","volume":"14","author":"Xu","year":"2008","journal-title":"Neuroscientist."},{"key":"B9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12640-009-9012-6","article-title":"Unconjugated TAT carrier peptide protects against excitotoxicity","volume":"15","author":"Vaslin","year":"2009","journal-title":"Neurotox Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainres.2010.09.007","article-title":"AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid","volume":"1360","author":"Meade","year":"2010","journal-title":"Brain Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1471-4159.2009.06459.x","article-title":"AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures","volume":"112","author":"Meade","year":"2010","journal-title":"J Neurochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10571-013-9999-3","article-title":"The neuroprotective efficacy of cell-penetrating peptides TAT penetratin Arg-9 and Pep-1 in glutamic acid kainic acid and in vitro ischemia injury models using primary cortical neuronal cultures","volume":"34","author":"Meloni","year":"2014","journal-title":"Cell Mol Neurobiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10989-010-9234-8","article-title":"Attenuation of neuronal death by peptide inhibitors of AP-1 activation in acute and delayed in vitro ischaemia (oxygen\/glucose deprivation) models","volume":"17","author":"Craig","year":"2011","journal-title":"Int J Pept Res Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"22030","DOI":"10.1074\/jbc.M115.662791","article-title":"Inhibition of N-methyl-D-aspartate-induced retinal neuronal death by polyarginine peptides is linked to the attenuation of stress-induced hyperpolarization of the inner mitochondrial membrane potential","volume":"290","author":"Marshall","year":"2015","journal-title":"J Biol Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/jcbfm.2015.11","article-title":"Poly-arginine and arginine-rich peptides are neuroprotective in stroke models","volume":"35","author":"Meloni","year":"2015","journal-title":"J Cereb Blood Flow Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12017-017-8441-2","article-title":"Assessment of the neuroprotective effects of arginine-rich protamine peptides poly-arginine peptides (R12-cylic R22) and arginine-tryptophan containing peptides following in vitro excitotoxicity and\/or permanent middle cerebral artery occlusion in rats","volume":"19","author":"Meloni","year":"2017","journal-title":"Neuromol Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11010-016-2882-z","article-title":"Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides in neuronal glutamic acid excitotoxicity model","volume":"426","author":"Edwards","year":"2017","journal-title":"Mol Cell Biochem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12868-016-0253-z","article-title":"Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model","volume":"17","author":"Milani","year":"2016","journal-title":"BMC Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2372710","DOI":"10.1155\/2016\/2372710","article-title":"The R18 polyarginine peptide is more effective than the TAT-NR2B9c (NA-1) peptide when administered 60 minutes after permanent middle cerebral artery occlusion in the rat","volume":"2016","author":"Milani","year":"2016","journal-title":"Stroke Res Treat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neures.2016.09.002","article-title":"Neuroprotective efficacy of R18 poly-arginine and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat","volume":"114","author":"Milani","year":"2017","journal-title":"Neurosci Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0193884","DOI":"10.1371\/journal.pone.0193884","article-title":"Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies","volume":"13","author":"Milani","year":"2018","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-018-0352-0","article-title":"Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat","volume":"11","author":"Edwards","year":"2018","journal-title":"Mol Brain."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/jnr.24315","article-title":"Assessment of therapeutic window for poly-arginine-18D (R18D) in a P7 rat model of perinatal hypoxic-ischaemic encephalopathy","volume":"96","author":"Edwards","year":"2018","journal-title":"J Neurosci Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1515\/tnsci-2017-0021","article-title":"Assessment of neuroprotective peptides poly-arginine R18 COG1410 and APP96\u2013110 experimental traumatic brain injury and in vitro neuronal excitotoxicity","volume":"15","author":"Chiu","year":"2017","journal-title":"Transl Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/(SICI)1097-4547(19990715)57:2<280::AID-JNR14>3.0.CO;2-U","article-title":"Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress possibly involved in neurodegenerative diseases","volume":"57","author":"Kikuchi","year":"1999","journal-title":"J Neurosci Res."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-019-00809-1","article-title":"Poly-arginine peptide-18 (R18) reduces brain injury and improves functional outcomes in a nonhuman primate stroke model","author":"Meloni","year":"2019","journal-title":"Neurotherapeutics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.3892\/etm.2019.7423","article-title":"Effect of poly-arginine R18 on neurocyte cell growth via autophagy in traumatic brain injury","volume":"17","author":"Batulu","year":"2019","journal-title":"Exp Ther Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1002\/cmdc.200800273","article-title":"Reduction of Alzheimer's disease amyloid plaque load in transgenic mice by D3, a D-enantiomeric peptide identified by mirror image phage display","volume":"3","author":"van Groen","year":"2008","journal-title":"ChemMedChem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16275","DOI":"10.1038\/s41598-017-16565-1","article-title":"The A\u03b2 oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology","volume":"7","author":"van Groen","year":"2017","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.npep.2017.11.011","article-title":"A\u03b2 oligomer eliminating compounds interfere successfully with pEA\u03b2(3\u201342) induced motor neurodegenerative phenotype in transgenic mice","volume":"67","author":"Dunkelmann","year":"2018","journal-title":"Neuropeptides"},{"key":"B31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ana.24087","article-title":"Innate defense regulator peptide 1018 protects against perinatal brain injury","volume":"75","author":"Bolouri","year":"2014","journal-title":"Ann Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1073\/pnas.1614728114","article-title":"Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a","volume":"114","author":"Chassagnon","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.brainres.2010.12.077","article-title":"The neuroprotective domains of the amyloid precursor protein in traumatic brain injury are located in the two growth factor domains","volume":"1378","author":"Corrigan","year":"2011","journal-title":"Brain Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/jnc.12391","article-title":"The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96\u2013110","volume":"128","author":"Corrigan","year":"2014","journal-title":"J Neurochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0190449","DOI":"10.1371\/journal.pone.0190449","article-title":"The amyloid precursor protein derivative APP96\u2013110 is efficacious following intravenous administration after traumatic brain injury","volume":"13","author":"Plummer","year":"2018","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"48529","DOI":"10.1074\/jbc.M306923200","article-title":"APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response","volume":"278","author":"Lynch","year":"2003","journal-title":"J Biol Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0306-4522(02)00709-1","article-title":"Protective effect of apolipoprotein E-mimetic peptides on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cell cultures","volume":"116","author":"Aono","year":"2003","journal-title":"Neuroscience."},{"key":"B38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.expneurol.2004.11.014","article-title":"A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury","volume":"192","author":"Lynch","year":"2005","journal-title":"Exp Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neulet.2005.02.036","article-title":"Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic-ischemic injury","volume":"381","author":"McAdoo","year":"2005","journal-title":"Neurosci Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1124\/jpet.106.103671","article-title":"Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis","volume":"318","author":"Li","year":"2006","journal-title":"J Pharmacol Exp Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e8191","DOI":"10.1371\/journal.pone.0008191","article-title":"Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease","volume":"4","author":"Sarantseva","year":"2009","journal-title":"PLoS ONE."},{"key":"B42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1385\/NCC:4:1:025","article-title":"A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid haemorrhage","volume":"4","author":"Gao","year":"2006","journal-title":"Neurocrit Care."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1089\/neu.2006.0254","article-title":"The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury","volume":"24","author":"Hoane","year":"2007","journal-title":"J Neurotrauma."},{"key":"B44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/neu.2008.0565","article-title":"COG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brain","volume":"26","author":"Hoane","year":"2009","journal-title":"J Neurotrauma."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1089\/neu.2012.2362","article-title":"Administration of COG1410 reduces axonal amyloid precursor protein immunoreactivity and microglial activation after controlled cortical impact in mice","volume":"29","author":"Jiang","year":"2012","journal-title":"J Neurotrauma."},{"key":"B46","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bbr.2010.06.017","article-title":"COG1410 an apolipoprotein E-based peptide improves cognitive performance and reduces cortical loss following moderate fluid percussion injury in the rat","volume":"214","author":"Kaufman","year":"2010","journal-title":"Behav Brain Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1089\/neu.2006.0192","article-title":"COG1410 a novel apolipoprotein E-based peptide improves functional recovery in a murine model of traumatic brain injury","volume":"24","author":"Laskowitz","year":"2007","journal-title":"J Neurotrauma."},{"key":"B48","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12028-011-9641-5","article-title":"The apoE-mimetic peptide COG1410 improves functional recovery in a murine model of intracerebral haemorrhage","volume":"16","author":"Laskowitz","year":"2012","journal-title":"Neurocrit Care."},{"key":"B49","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/STROKEAHA.108.530402","article-title":"Pharmacogenomic effects of apolipoprotein E on intracerebral haemorrhage","volume":"40","author":"James","year":"2009","journal-title":"Stroke."},{"key":"B50","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jnr.21874","article-title":"COG1410 a novel apolipoprotein-E mimetic improves functional and morphological recovery in a rat model of focal brain ischemia","volume":"87","author":"Tukhovskaya","year":"2009","journal-title":"J Neurosci Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/jnr.23371","article-title":"ApoE mimetic ameliorates motor deficit and tissue damage in rat spinal cord injury","volume":"92","author":"Wang","year":"2014","journal-title":"J Neurosci Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neulet.2016.05.058","article-title":"An apoE-derived mimic peptide COG1410 alleviates early brain injury via reducing apoptosis and neuroinflammation in a mouse model of subarachnoid haemorrhage","volume":"627","author":"Wu","year":"2016","journal-title":"Neurosci Lett."},{"key":"B53","doi-asserted-by":"publisher","first-page":"34834","DOI":"10.1038\/srep34834","article-title":"Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral haemorrhage","volume":"6","author":"Lei","year":"2016","journal-title":"Sci Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"46461","DOI":"10.1038\/srep46461","article-title":"Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model","volume":"7","author":"Laskowitz","year":"2017","journal-title":"Sci Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/acn3.399","article-title":"Apolipoprotein E mimetic peptide CN-105 improves outcomes in ischemic stroke","volume":"4","author":"Tu","year":"2017","journal-title":"Ann Clin Transl Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2005.04.056","article-title":"Synthetic fibronectin peptide exerts neuroprotective effects on transient focal brain ischemia in rats","volume":"1054","author":"Zhao","year":"2005","journal-title":"Brain Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.neuroscience.2010.03.040","article-title":"The neuroprotective effects of fibronectin mats and fibronectin peptides following spinal cord injury in the rat","volume":"168","author":"King","year":"2010","journal-title":"Neuroscience."},{"key":"B58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2006.12.015","article-title":"Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents","volume":"560","author":"Khroyan","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1126\/science.1072873","article-title":"Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions","volume":"298","author":"Aarts","year":"2002","journal-title":"Science."},{"key":"B60","doi-asserted-by":"publisher","first-page":"10696","DOI":"10.1523\/JNEUROSCI.1207-08.2008","article-title":"Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand","volume":"28","author":"Soriano","year":"2008","journal-title":"J Neurosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/STROKEAHA.107.506048","article-title":"Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat","volume":"39","author":"Sun","year":"2008","journal-title":"Stroke."},{"key":"B62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1161\/STROKEAHA.111.618801","article-title":"Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor","volume":"42","author":"Br\u00e5tane","year":"2011","journal-title":"Stroke."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/mt.2011.42","article-title":"Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain","volume":"19","author":"D'Mello","year":"2012","journal-title":"Mol Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature10841","article-title":"Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain","volume":"483","author":"Cook","year":"2012","journal-title":"Nature."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1038\/jcbfm.2013.153","article-title":"Uncoupling PSD-95 interactions leads to rapid recovery of cortical function after focal stroke","volume":"33","author":"Srejic","year":"2013","journal-title":"J Cereb Blood Flow Metab."},{"key":"B67","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1007\/s12035-015-9488-4","article-title":"Neuroprotective effects of a PSD-95 inhibitor in neonatal hypoxic-ischemic brain injury","volume":"53","author":"Xu","year":"2016","journal-title":"Mol Neurobiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1177\/0271678X18762637","article-title":"Treatment of secondary brain injury by perturbing postsynaptic density protein-95-NMDA receptor interaction after intracerebral hemorrhage in rats","volume":"39","author":"Wang","year":"2019","journal-title":"J Cereb Blood Flow Metab."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nm911","article-title":"A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia","volume":"9","author":"Borsello","year":"2003","journal-title":"Nat Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1161\/01.STR.0000131480.03994.b1","article-title":"D-JNKI1 a cell-penetrating c-Jun-N-terminal kinase inhibitor protects against cell death in severe cerebral ischemia","volume":"35","author":"Hirt","year":"2004","journal-title":"Stroke."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1523\/JNEUROSCI.5290-05.2006","article-title":"A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance","volume":"26","author":"Zhuang","year":"2006","journal-title":"J Neurosci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/sj.cdd.4401988","article-title":"Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons","volume":"14","author":"Centeno","year":"2007","journal-title":"Cell Death Differ."},{"key":"B73","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuroscience.2007.12.036","article-title":"D-JNKi a peptide inhibitor of c-Jun N-terminal kinase promotes functional recovery after transient focal cerebral ischemia in rats","volume":"152","author":"Esneault","year":"2008","journal-title":"Neuroscience."},{"key":"B74","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000151639","article-title":"The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator","volume":"26","author":"Wiegler","year":"2008","journal-title":"Cerebrovasc Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/NEN.0b013e3181ac6b70","article-title":"Neuroprotection after status epilepticus by targeting protein interactions with postsynaptic density protein 95","volume":"68","author":"Dykstra","year":"2009","journal-title":"J Neuropathol Exp Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1471-4159.2008.05797.x","article-title":"Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia-ischemia","volume":"108","author":"Ginet","year":"2009","journal-title":"J Neurochem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/NEN.0b013e3181b20670","article-title":"c-Jun N-terminal kinase pathway activation in human and experimental cerebral contusion","volume":"68","author":"Ortolano","year":"2009","journal-title":"J Neuropathol Exp Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/j.1471-4159.2010.06705.x","article-title":"Role of the c-Jun N-terminal kinase pathway in retinal excitotoxicity and neuroprotection by its inhibition","volume":"113","author":"Bessero","year":"2010","journal-title":"J Neurochem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1159\/000306643","article-title":"c-Jun N-terminal kinase pathway inhibition in intracerebral haemorrhage","volume":"29","author":"Michel-Monigadon","year":"2010","journal-title":"Cerebrovasc Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/j.1460-9568.2010.07158.x","article-title":"c-Jun N-terminal kinase signaling pathway in excitotoxic cell death following kainic acid-induced status epilepticus","volume":"31","author":"Spigolon","year":"2010","journal-title":"Eur J Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"43871","DOI":"10.1074\/jbc.M111.297515","article-title":"c-Jun N-terminal kinase regulates soluble A\u03b2 oligomers and cognitive impairment in AD mouse model","volume":"286","author":"Sclip","year":"2011","journal-title":"J Biol Chem."},{"key":"B82","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.nbd.2012.03.014","article-title":"Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury","volume":"46","author":"Repici","year":"2012","journal-title":"Neurobiol Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fnmol.2018.00308","article-title":"Pharmacological c-Jun NH2-terminal kinase (JNK) pathway inhibition reduces severity of spinal muscular atrophy disease in mice","volume":"11","author":"Schellino","year":"2018","journal-title":"Front Mol Neurosci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/sj.jcbfm.9600062","article-title":"Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway","volume":"25","author":"Gao","year":"2005","journal-title":"J Cereb Blood Flow Metab."},{"key":"B85","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.neuroscience.2005.11.067","article-title":"Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways","volume":"139","author":"Guan","year":"2006","journal-title":"Neuroscience."},{"key":"B86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1471-4159.2007.04618.x","article-title":"Necrotic death of neurons following an excitotoxic insult is prevented by a peptide inhibitor of c-jun N-terminal kinase","volume":"102","author":"Arthur","year":"2007","journal-title":"J Neurochem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1523\/JNEUROSCI.4474-03.2004","article-title":"Protein kinase C delta mediates cerebral reperfusion injury in vivo","volume":"24","author":"Bright","year":"2004","journal-title":"J Neurosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.brainres.2007.01.113","article-title":"DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo","volume":"1144","author":"Bright","year":"2007","journal-title":"Brain Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.bbi.2009.09.008","article-title":"Inhibition of the JNK\/AP-1 pathway reduces neuronal death and improves behavioral outcome after neonatal hypoxic-ischemic brain injury","volume":"24","author":"Nijboer","year":"2010","journal-title":"Brain Behav Immun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.nbd.2013.01.017","article-title":"Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage","volume":"54","author":"Nijboer","year":"2013","journal-title":"Neurobiol Dis"},{"key":"B91","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuropharm.2019.02.035","article-title":"Selectivity efficacy and toxicity studies of UCCB01\u2013144 a dimeric neuroprotective PSD-95 inhibitor","volume":"150","author":"Bach","year":"2019","journal-title":"Neuropharmacology."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1073\/pnas.1113761109","article-title":"A high-affinity dimeric inhibitor of PSD-95 bivalently interacts with PDZ1\u20132 and protects against ischemic brain damage","volume":"109","author":"Bach","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B93","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejphar.2016.03.045","article-title":"Effects of the dimeric PSD-95 inhibitor UCCB01\u2013144 in mouse models of pain cognition and motor function","volume":"780","author":"Andreasen","year":"2016","journal-title":"Eur J Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1177\/0271678X16645595","article-title":"PSD-95 uncoupling from NMDA receptors by Tat-N-dimer ameliorates neuronal depolarization in cortical spreading depression","volume":"37","author":"Kucharz","year":"2017","journal-title":"J Cereb Blood Flow Metab."},{"key":"B95","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuropharm.2019.04.028","article-title":"Targeting PSD95-nNOS interaction by Tat-N-dimer peptide during status epilepticus is neuroprotective in MAM-pilocarpine rat model","volume":"153","author":"Colciaghi","year":"2019","journal-title":"Neuropharmacology."},{"key":"B96","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/labinvest.2009.124","article-title":"Small peptide inhibitor of JNKs protects against MPTP-induced nigral dopaminergic injury via inhibiting the JNK-signaling pathway","volume":"90","author":"Pan","year":"2010","journal-title":"Lab Invest."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e0119204","DOI":"10.1371\/journal.pone.0119204","article-title":"Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway","volume":"10","author":"Pan","year":"2015","journal-title":"PLoS ONE."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/nm.1883","article-title":"Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex","volume":"14","author":"Liu","year":"2008","journal-title":"Nat Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1074\/jbc.M112.421354","article-title":"Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo","volume":"288","author":"Chambers","year":"2013","journal-title":"J Biol Chem."},{"key":"B100","doi-asserted-by":"publisher","first-page":"37778","DOI":"10.1074\/jbc.M111.255455","article-title":"Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2)","volume":"286","author":"Brittain","year":"2011","journal-title":"J Biol Chem"},{"key":"B101","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm.2345","article-title":"Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2+ channel complex","volume":"17","author":"Brittain","year":"2011","journal-title":"Nat Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4161\/chan.18919","article-title":"Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model","volume":"6","author":"Brittain","year":"2012","journal-title":"Channels."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1744-8069-8-54","article-title":"CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels attenuation of nociceptor excitability and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy","volume":"8","author":"Piekarz","year":"2012","journal-title":"Mol Pain."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/s13380-012-0002-4","article-title":"A peptide uncoupling CRMP-2 from the presynaptic Ca2+ channel complex demonstrates efficacy in animal models of migraine and aids therapy-induced neuropathy","volume":"3","author":"Ripsch","year":"2012","journal-title":"Transl Neurosci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3389\/fncel.2014.00471","article-title":"Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic hydrophobic and amphipathic cell penetrating peptides","volume":"8","author":"Moutal","year":"2015","journal-title":"Front Cell Neurosci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1471-4159.2011.07209.x","article-title":"Proteomic analysis of cPKC\u03b2II-interacting proteins involved in HPC-induced neuroprotection against cerebral ischemia of mice","volume":"117","author":"Bu","year":"2011","journal-title":"J Neurochem."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s11064-013-1118-9","article-title":"Tat-collapsin response mediator protein 2 (CRMP2) increases the survival of neurons after NMDA excitotoxity by reducing the cleavage of CRMP2","volume":"38","author":"Yin","year":"2013","journal-title":"Neurochem Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/jnc.13538","article-title":"Conventional protein kinase C\u03b2-mediated phosphorylation inhibits collapsin response-mediated protein 2 proteolysis and alleviates ischemic injury in cultured cortical neurons and ischemic stroke-induced mice","volume":"137","author":"Yang","year":"2016","journal-title":"J Neurochem."},{"key":"B109","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pharmthera.2015.06.002","article-title":"Neuroprotective peptides fused to arginine-rich cell penetrating peptides: neuroprotective mechanism likely mediated by peptide endocytic properties","volume":"153","author":"Meloni","year":"2015","journal-title":"Pharmacol Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e17161","DOI":"10.7554\/eLife.17161.024","article-title":"Pro-death NMDA receptor signaling is promoted by the GluN2B C-terminus independently of Dapk1","volume":"6","author":"McQueen","year":"2017","journal-title":"Elife."},{"key":"B111","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cell.2009.12.055","article-title":"DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke","volume":"140","author":"Tu","year":"2010","journal-title":"Cell."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/nm.2263","article-title":"Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects","volume":"16","author":"Pei","year":"2010","journal-title":"Nat Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1124\/jpet.110.167882","article-title":"An apolipoprotein E-mimetic stimulates axonal regeneration and remyelination after peripheral nerve injury","volume":"334","author":"Li","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"B114","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000341299","article-title":"The apolipoprotein-E-mimetic COG112 protects amyloid precursor protein intracellular domain-overexpressing animals from Alzheimer's disease-like pathological features","volume":"12","author":"Ghosal","year":"2013","journal-title":"Neurodegener Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4172\/2155-9562.S12-010","article-title":"Apolipoprotein E mimetic promotes functional and histological recovery in lysolecithin-induced spinal cord demyelination in mice","volume":"2014","author":"Gu","year":"2013","journal-title":"J Neurol Neurophysiol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nn.3637","article-title":"Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation","volume":"17","author":"Fan","year":"2014","journal-title":"Nat Neurosci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.neuroscience.2010.02.031","article-title":"A cyclic peptide targeted against PSD-95 blocks central sensitization and attenuates thermal hyperalgesia","volume":"167","author":"LeBlanc","year":"2010","journal-title":"Neuroscience."},{"key":"B118","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40478-014-0086-x","article-title":"Systemic delivery of P42 peptide: a new weapon to fight Huntington's disease","volume":"2","author":"Arribat","year":"2014","journal-title":"Acta Neuropathol Commun."},{"key":"B119","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1523\/JNEUROSCI.5119-13.2014","article-title":"DAPK1-p53 interaction converges necrotic and apoptotic pathways of ischemic neuronal death","volume":"34","author":"Pei","year":"2014","journal-title":"J Neurosci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1161\/STROKEAHA.114.006348","article-title":"Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke","volume":"45","author":"Wang","year":"2014","journal-title":"Stroke."},{"key":"B121","doi-asserted-by":"publisher","first-page":"20675","DOI":"10.1074\/jbc.M109.088617","article-title":"Effective post-insult neuroprotection by a novel Ca2+\/calmodulin-dependent protein kinase II (CaMKII) inhibitor","volume":"285","author":"Vest","year":"2010","journal-title":"J Biol Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.mcn.2011.02.003","article-title":"Excitotoxic neuroprotection and vulnerability with CaMKII inhibition","volume":"46","author":"Ashpole","year":"2011","journal-title":"Mol Cell Neurosci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12031-016-0830-8","article-title":"Beneficial effects of a CaMKII\u03b1 inhibitor TatCN21 peptide in global cerebral ischemia","volume":"61","author":"Ahmed","year":"2017","journal-title":"J Mol Neurosci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/brain\/awh700","article-title":"Neuroprotection against ischaemic brain injury by a GluR6\u20139c peptide containing the TAT protein transduction sequence","volume":"129","author":"Pei","year":"2006","journal-title":"Brain."},{"key":"B125","doi-asserted-by":"publisher","first-page":"17432","DOI":"10.1074\/jbc.M513490200","article-title":"Neuroprotection of Tat-GluR6\u20139c against neuronal death induced by kainate in rat hippocampus via nuclear and non-nuclear pathways","volume":"281","author":"Liu","year":"2006","journal-title":"J Biol Chem."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1007\/s11064-009-9990-z","article-title":"Neuroprotection against transient focal cerebral ischemia and oxygen-glucose deprivation by interference with GluR6-PSD95 protein interaction","volume":"34","author":"Yu","year":"2009","journal-title":"Neurochem Res."},{"key":"B127","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuron.2006.12.020","article-title":"Calpain-mediated mGluR1alpha truncation: a key step in excitotoxicity","volume":"53","author":"Xu","year":"2007","journal-title":"Neuron."},{"key":"B128","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.expneurol.2009.04.006","article-title":"Neuroprotection against neonatal hypoxia\/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation","volume":"218","author":"Zhou","year":"2009","journal-title":"Exp Neurol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1021\/acschemneuro.8b00531","article-title":"TAT-mGluR1 attenuation of neuronal apoptosis through prevention of mGluR1\u03b1 truncation after experimental subarachnoid hemorrhage","volume":"10","author":"Wang","year":"2018","journal-title":"ACS Chem Neurosci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"7997","DOI":"10.1523\/JNEUROSCI.5661-12.2013","article-title":"Critical role of increased PTEN nuclear translocation in excitotoxic and ischemic neuronal injuries","volume":"33","author":"Zhang","year":"2013","journal-title":"J Neurosci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/nm.2064","article-title":"Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries","volume":"15","author":"Taghibiglou","year":"2009","journal-title":"Nat Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"8185","DOI":"10.1523\/JNEUROSCI.4578-12.2013","article-title":"The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death","volume":"33","author":"Li","year":"2013","journal-title":"J Neurosci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1523\/JNEUROSCI.0037-15.2015","article-title":"Unexpected heterodivalent recruitment of NOS1AP to nNOS reveals multiple sites for pharmacological intervention in neuronal disease models","volume":"35","author":"Li","year":"2015","journal-title":"J Neurosci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/j.pain.0000000000001152","article-title":"Disruption of nNOS-NOS1AP protein-protein interactions suppresses neuropathic pain in mice","volume":"159","author":"Lee","year":"2018","journal-title":"Pain."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/ALN.0b013e318173f66b","article-title":"Trans-activator of transcription-mediated delivery of NEP1\u201340 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis","volume":"108","author":"Wang","year":"2008","journal-title":"Anesthesiology."},{"key":"B136","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10571-008-9301-2","article-title":"TAT-mediated protein transduction of Nogo extracellular peptide 1\u201340 and its biological activity","volume":"29","author":"Wang","year":"2009","journal-title":"Cell Mol Neurobiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.nbd.2010.01.016","article-title":"NF-kappaB inhibition after neonatal cerebral hypoxia-ischemia improves long-term motor and cognitive outcome in rats","volume":"38","author":"van der Kooij","year":"2010","journal-title":"Neurobiol Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/jnr.23186","article-title":"Selective activation of protein kinase C\u03f5 in mitochondria is neuroprotective in vitro and reduces focal ischemic brain injury in mice","volume":"91","author":"Sun","year":"2013","journal-title":"J Neurosci Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.1073\/pnas.1611282113","article-title":"Autophagy induction stabilizes microtubules and promotes axon regeneration after spinal cord injury","volume":"113","author":"He","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B140","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/10715762.2017.1311015","article-title":"Involvement of Nox2 and Nox4 NADPH oxidases in early brain injury after subarachnoid haemorrhage","volume":"51","author":"Zhang","year":"2017","journal-title":"Free Radic Res."},{"key":"B141","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12974-015-0391-8","article-title":"Inhibition of NOX2 reduces locomotor impairment inflammation and oxidative stress after spinal cord injury","volume":"12","author":"Khayrullina","year":"2015","journal-title":"J Neuroinflammation."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e34504","DOI":"10.1371\/journal.pone.0034504","article-title":"Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE."},{"key":"B143","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nature13974","article-title":"Modulation of the proteoglycan receptor PTP\u03c3 promotes recovery after spinal cord injury","volume":"518","author":"Lang","year":"2015","journal-title":"Nature."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.neuron.2014.07.036","article-title":"The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav32 channel activity","volume":"83","author":"Garc\u00eda-Caballero","year":"2014","journal-title":"Neuron."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e71650","DOI":"10.1371\/annotation\/7a8aaf1d-e968-4b39-abb0-867d6078b2af","article-title":"Inhibitory peptide of mitochondrial \u03bc-calpain protects against photoreceptor degeneration in rhodopsin transgenic S334ter and P23H rats","volume":"8","author":"Ozaki","year":"2013","journal-title":"PLoS ONE."},{"key":"B146","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/jnc.12070","article-title":"Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide","volume":"124","author":"Ju","year":"2013","journal-title":"J Neurochem."},{"key":"B147","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.1523\/JNEUROSCI.2212-09.2009","article-title":"Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP","volume":"29","author":"Xu","year":"2009","journal-title":"J Neurosci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"e1939","DOI":"10.1038\/cddis.2015.307","article-title":"Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220\/ARMS calpain processing induced by excitotoxicity","volume":"6","author":"Gamir-Morralla","year":"2015","journal-title":"Cell Death Dis."},{"key":"B149","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1084\/jem.20160776","article-title":"Potential biomarkers to follow the progression and treatment response of Huntington's disease","volume":"213","author":"Disatnik","year":"2016","journal-title":"J Exp Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1042\/BJ20131438","article-title":"Drp1 stabilizes p53 on the mitochondria to trigger necrosis under oxidative stress conditions in vitro and in vivo","volume":"461","author":"Guo","year":"2014","journal-title":"Biochem J."},{"key":"B151","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1172\/JCI43165","article-title":"Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats","volume":"120","author":"Du","year":"2010","journal-title":"J Clin Invest."},{"key":"B152","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.biochi.2015.06.008","article-title":"Novel endomorphin-1 analogs with C-terminal oligoarginine-conjugation display systemic antinociceptive activity with less gastrointestinal side effects","volume":"116","author":"Wang","year":"2015","journal-title":"Biochimie."},{"key":"B153","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.nbd.2015.12.013","article-title":"The cell-permeable A\u03b21\u20136A2VTAT(D) peptide reverts synaptopathy induced by A\u03b21\u201342wt","volume":"89","author":"Cimini","year":"2016","journal-title":"Neurobiol Dis."},{"key":"B154","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1523\/JNEUROSCI.1304-15.2015","article-title":"Cell-permeable peptide targeting the Nrf2-Keap1 interaction: a potential novel therapy for global cerebral ischemia","volume":"35","author":"Tu","year":"2015","journal-title":"J Neurosci."},{"key":"B155","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.expneurol.2015.09.005","article-title":"Phosphorylation of TRPV1 by cyclin-dependent kinase 5 promotes TRPV1 surface localization leading to inflammatory thermal hyperalgesia","volume":"273","author":"Liu","year":"2015","journal-title":"Exp Neurol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"7575","DOI":"10.1523\/JNEUROSCI.1312-10.2010","article-title":"The DREAM protein negatively regulates the NMDA receptor through interaction with the NR1 subunit","volume":"30","author":"Zhang","year":"2010","journal-title":"J Neurosci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1523\/JNEUROSCI.3811-16.2017","article-title":"Targeting a potassium channel\/syntaxin interaction ameliorates cell death in ischemic stroke","volume":"37","author":"Yeh","year":"2017","journal-title":"J Neurosci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuropharm.2017.07.034","article-title":"Disruption of 5-HT2A-PDZ protein interaction differently affects the analgesic efficacy of SSRI SNRI and TCA in the treatment of traumatic neuropathic pain in rats","volume":"125","author":"Wattiez","year":"2017","journal-title":"Neuropharmacology."},{"key":"B159","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41418-018-0116-5","article-title":"A novel cell-penetrating peptide protects against neuron apoptosis after cerebral ischemia by inhibiting the nuclear translocation of annexin A1","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death Differ."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1111\/bph.13737","article-title":"Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides","volume":"175","author":"Moutal","year":"2018","journal-title":"Br J Pharmacol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.peptides.2017.11.011","article-title":"A new tridecapeptide with an octaarginine vector has analgesic therapeutic potential and prevents morphine-induced tolerance","volume":"99","author":"Kashkin","year":"2018","journal-title":"Peptides."},{"key":"B162","doi-asserted-by":"publisher","first-page":"120616","DOI":"10.1172\/JCI120616","article-title":"Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington's disease","volume":"130","author":"Vezzoli","year":"2019","journal-title":"J Clin Invest."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/j.1471-4159.2007.04645.x","article-title":"Apelin an endogenous neuronal peptide protects hippocampal neurons against excitotoxic injury","volume":"102","author":"O'Donnell","year":"2007","journal-title":"J Neurochem."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1471-4159.2011.07383.x","article-title":"NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury","volume":"118","author":"Cook","year":"2011","journal-title":"J Neurochem."},{"key":"B165","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejphar.2016.08.036","article-title":"Apelin-36 is protective against N-methyl-D-aspartic-acid-induced retinal ganglion cell death in the mice","volume":"791","author":"Sakamoto","year":"2016","journal-title":"Eur J Pharmacol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jphs.2016.12.002","article-title":"Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1\/2 and suppressing TNF-\u03b1 expression in mice","volume":"133","author":"Ishimaru","year":"2017","journal-title":"J Pharmacol Sci"},{"key":"B167","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.neuint.2013.09.017","article-title":"Apelin-36 a potent peptide protects against ischemic brain injury by activating the PI3K\/Akt pathway","volume":"63","author":"Gu","year":"2013","journal-title":"Neurochem Int."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1759091415605114","article-title":"Intranasal delivery of apelin-13 is neuroprotective and oromotes angiogenesis after ischemic stroke in mice","volume":"7","author":"Chen","year":"2015","journal-title":"ASN Neuro"},{"key":"B169","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.peptides.2015.11.002","article-title":"Apelin-13 protects against apoptosis by activating AMP-activated protein kinase pathway in ischemia stroke","volume":"75","author":"Yang","year":"2016","journal-title":"Peptides."},{"key":"B170","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2174\/97816810853261170401","article-title":"Low dose of apelin-36 attenuates ER stress-associated apoptosis in rats with ischemic stroke","volume":"8","author":"Qiu","year":"2017","journal-title":"Front Neurol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.peptides.2009.02.011","article-title":"Supraspinal administration of apelin-13 induces antinociception via the opioid receptor in mice","volume":"30","author":"Xu","year":"2009","journal-title":"Peptides."},{"key":"B172","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12031-012-9808-3","article-title":"Apelin-13 protects the brain against ischemic reperfusion injury and cerebral edema in a transient model of focal cerebral ischemia","volume":"48","author":"Khaksari","year":"2012","journal-title":"J Mol Neurosci."},{"key":"B173","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neulet.2016.06.046","article-title":"The neuroprotective effect of apelin-13 in a mouse model of intracerebral haemorrhage","volume":"628","author":"Bao","year":"2016","journal-title":"Neurosci Lett."},{"key":"B174","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11064-014-1469-x","article-title":"Apelin-13 attenuates traumatic brain injury-induced damage by suppressing autophagy","volume":"40","author":"Bao","year":"2015","journal-title":"Neurochem Res."},{"key":"B175","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.peptides.2014.09.016","article-title":"Neuroprotective effects of apelin-13 on experimental ischemic stroke through suppression of inflammation","volume":"63","author":"Xin","year":"2015","journal-title":"Peptides."},{"key":"B176","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.npep.2016.08.010","article-title":"Chronic administration of [Pyr1] apelin-13 attenuates neuropathic pain after compression spinal cord injury in rats","volume":"61","author":"Hajimashhadi","year":"2017","journal-title":"Neuropeptides."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.neuint.2008.01.007","article-title":"Opioids modulate post-ischemic progression in a rat model of stroke","volume":"52","author":"Kao","year":"2008","journal-title":"Neurochem Int."},{"key":"B178","first-page":"1133","article-title":"Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage","volume":"298","author":"Liu","year":"2001","journal-title":"J Pharmacol Exp Ther."},{"key":"B179","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4155\/fmc.15.164","article-title":"Dynorphin A analogs for the treatment of chronic neuropathic pain","volume":"8","author":"Hall","year":"2016","journal-title":"Future Med Chem."},{"key":"B180","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/0304-3940(94)11161-B","article-title":"Antinociceptive effect of intrathecally administered pituitary adenylate cyclase activating polypeptide (PACAP) on the rat formalin test","volume":"184","author":"Yamamoto","year":"1995","journal-title":"Neurosci Lett."},{"key":"B181","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0006-8993(96)00716-0","article-title":"Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide","volume":"736","author":"Uchida","year":"1996","journal-title":"Brain Res."},{"key":"B182","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0006-8993(99)01690-X","article-title":"Attenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neurons","volume":"839","author":"Shoge","year":"1999","journal-title":"Brain Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12031-008-9089-z","article-title":"Agonistic behavior of PACAP6\u201338 on sensory nerve terminals and cytotrophoblast cells","volume":"36","author":"Reglodi","year":"2008","journal-title":"J Mol Neurosci."},{"key":"B184","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bbr.2003.09.007","article-title":"Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease","volume":"151","author":"Reglodi","year":"2004","journal-title":"Behav Brain Res."},{"key":"B185","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/S0196-9781(02)00262-0","article-title":"Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia","volume":"23","author":"Reglodi","year":"2002","journal-title":"Peptides."},{"key":"B186","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.neuropharm.2006.04.009","article-title":"Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system","volume":"51","author":"Sibilia","year":"2006","journal-title":"Neuropharmacology."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1089\/neu.2009.1210","article-title":"The anti-inflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats","volume":"27","author":"Er\u015fahin","year":"2010","journal-title":"J Neurotrauma."},{"key":"B188","doi-asserted-by":"publisher","first-page":"14057","DOI":"10.1523\/JNEUROSCI.3890-09.2009","article-title":"Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism","volume":"29","author":"Andrews","year":"2009","journal-title":"J Neurosci."},{"key":"B189","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1507\/endocrj.K09E-072","article-title":"Neuroprotective effect of ghrelin is associated with decreased expression of prostate apoptosis response-4","volume":"56","author":"Hwang","year":"2009","journal-title":"Endocr J."},{"key":"B190","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.brainres.2012.10.031","article-title":"Early ghrelin treatment attenuates disruption of the blood brain barrier and apoptosis after traumatic brain injury through a UCP-2 mechanism","volume":"1489","author":"Lopez","year":"2012","journal-title":"Brain Res."},{"key":"B191","doi-asserted-by":"publisher","first-page":"59929","DOI":"10.18632\/oncotarget.18349","article-title":"Preclinical evidence of ghrelin as a therapeutic target in epilepsy","volume":"8","author":"Ge","year":"2017","journal-title":"Oncotarget."},{"key":"B192","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/hipo.23002","article-title":"Chronic ghrelin administration restores hippocampal long-term potentiation and ameliorates memory impairment in rat model of Alzheimer's disease","volume":"28","author":"Eslami","year":"2018","journal-title":"Hippocampus."},{"key":"B193","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1161\/01.STR.0000242772.94277.1f","article-title":"Humanin is a novel neuroprotective agent against stroke","volume":"37","author":"Xu","year":"2006","journal-title":"Stroke."},{"key":"B194","doi-asserted-by":"publisher","first-page":"e16259","DOI":"10.1371\/journal.pone.0016259","article-title":"A humanin derivative reduces amyloid beta accumulation and ameliorates memory deficit in triple transgenic mice","volume":"6","author":"Niikura","year":"2011","journal-title":"PLoS ONE."},{"key":"B195","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbr.2013.03.023","article-title":"[Gly14]-Humanin offers neuroprotection through glycogen synthase kinase-3\u03b2 inhibition in a mouse model of intracerebral hemorrhage","volume":"247","author":"Wang","year":"2013","journal-title":"Behav Brain Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hipo.22350","article-title":"Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic\/ischemic brains","volume":"25","author":"Chen","year":"2015","journal-title":"Hippocampus."},{"key":"B197","doi-asserted-by":"publisher","first-page":"E2982","DOI":"10.3390\/ijms19102982","article-title":"Humanin attenuates NMDA-induced excitotoxicity by inhibiting ROS-dependent JNK\/p38 MAPK pathway","volume":"19","author":"Yang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B198","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1747-0285.2007.00540.x","article-title":"The antimicrobial peptide PR-39 has a protective effect against HeLa cell apoptosis","volume":"70","author":"Ross","year":"2007","journal-title":"Chem Biol Drug Des."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1161\/01.CIR.0000124067.35915.E0","article-title":"PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2","volume":"109","author":"Wu","year":"2004","journal-title":"Circulation."},{"key":"B200","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1152\/ajpheart.2001.281.6.H2612","article-title":"PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated I kappa B alpha degradation","volume":"281","author":"Bao","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/mp100223d","article-title":"The pharmacokinetics of cell-penetrating peptides","volume":"7","author":"Sarko","year":"2010","journal-title":"Mol Pharm."},{"key":"B202","doi-asserted-by":"publisher","first-page":"e0139652","DOI":"10.1371\/journal.pone.0139652","article-title":"Cell-penetrating peptides selectively cross the blood-brain barrier in vivo","volume":"10","author":"Stalmans","year":"2015","journal-title":"PLoS ONE."},{"key":"B203","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1016\/j.bmc.2017.11.004","article-title":"An opportunistic route to success: towards a change of paradigm to fully exploit the potential of cell-penetrating peptides","volume":"26","author":"Collado Camps","year":"2018","journal-title":"Bioorg Med Chem."},{"key":"B204","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1096\/fj.12-216176","article-title":"Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis","volume":"27","author":"Bechara","year":"2013","journal-title":"FASEB J."},{"key":"B205","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00018-014-1696-y","article-title":"Massive glycosaminoglycan-dependent entry of Trp-containing cell-penetrating peptides induced by exogenous sphingomyelinase or cholesterol depletion","volume":"72","author":"Bechara","year":"2015","journal-title":"Cell Mol Life Sci."},{"key":"B206","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.bbamem.2014.11.013","article-title":"The role of tryptophans on the cellular uptake and membrane interaction of arginine-rich cell penetrating peptides","volume":"1848","author":"Jobin","year":"2015","journal-title":"Biochim Biophys Acta."},{"key":"B207","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1021\/bi300454k","article-title":"Effects of tryptophan content and backbone spacing on the uptake efficiency of cell-penetrating peptides","volume":"51","author":"Rydberg","year":"2012","journal-title":"Biochemistry."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.bbamem.2012.02.024","article-title":"Membrane interactions of two arginine-rich peptides with different cell internalization capacities","volume":"1818","author":"Walrant","year":"2012","journal-title":"Biochim Biophys Acta."},{"key":"B209","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1124\/jpet.301.3.981","article-title":"The arginine-rich hexapeptide R4W2 is a stereoselective antagonist at the vanilloid receptor 1: a Ca2+ imaging study in adult rat dorsal root ganglion neurons","volume":"301","author":"Himmel","year":"2002","journal-title":"J Pharmacol Exp Ther."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science."},{"key":"B211","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","article-title":"Polyarginine enters cells more efficiently than other polycationic homopolymers","volume":"56","author":"Mitchell","year":"2000","journal-title":"J Pept Res."},{"key":"B212","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/jnen\/nlz014","article-title":"Poly-arginine peptides R18 and R18D improve functional outcomes after endothelin-1 (ET-1)-induced stroke in the Sprague Dawley rat","volume":"78","author":"Meloni","year":"2019","journal-title":"J Neuropathol Exp Neurol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/0022034516679973","article-title":"Antimicrobial peptides: mechanisms of action and resistance","volume":"96","author":"Bechinger","year":"2017","journal-title":"J Dent Res."},{"key":"B214","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pharmthera.2017.10.010","article-title":"Antimicrobial peptides nanotechnology and natural metabolites as novel approaches for cancer treatment","volume":"183","author":"Leite","year":"2018","journal-title":"Pharmacol Ther."},{"key":"B215","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1016\/j.jmb.2016.05.020","article-title":"Gangliosides of the vertebrate nervous system","volume":"428","author":"Schnaar","year":"2016","journal-title":"J Mol Biol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/tra.12100","article-title":"Sialic acid linkage in glycosphingolipids is a molecular correlate for trafficking and delivery of extracellular cargo","volume":"14","author":"Ravindran","year":"2013","journal-title":"Traffic"},{"key":"B217","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5650\/jos.60.537","article-title":"Structures biosynthesis and functions of gangliosides-an overview","volume":"60","author":"Yu","year":"2011","journal-title":"J Oleo Sci."},{"key":"B218","doi-asserted-by":"publisher","first-page":"8976","DOI":"10.1021\/bi027001j","article-title":"Molecular dynamics simulations of pentapeptides at interfaces: salt bridge and cation-pi interactions","volume":"42","author":"Aliste","year":"2003","journal-title":"Biochemistry."},{"key":"B219","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1021\/ar300265y","article-title":"The cation-\u03c0 interaction","volume":"46","author":"Dougherty","year":"2013","journal-title":"Acc Chem Res."},{"key":"B220","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jconrel.2006.10.031","article-title":"The taming of the cell penetrating domain of the HIV Tat: myths and realities","volume":"117","author":"Chauhan","year":"2007","journal-title":"J Control Release."},{"key":"B221","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.addr.2007.10.016","article-title":"The design of guanidinium-rich transporters and their internalization mechanisms","volume":"60","author":"Wender","year":"2008","journal-title":"Adv Drug Deliv Rev."},{"key":"B222","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1074\/jbc.M006701200","article-title":"Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans","volume":"276","author":"Tyagi","year":"2001","journal-title":"J Biol Chem."},{"key":"B223","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1074\/jbc.M110017200","article-title":"Possible existence of common internalization mechanisms among arginine-rich peptides","volume":"277","author":"Suzuki","year":"2002","journal-title":"J Biol Chem."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1248\/cpb.c16-00505","article-title":"Current understanding of direct translocation of arginine-rich cell-penetrating peptides and its internalization mechanisms","volume":"64","author":"Takeuchi","year":"2016","journal-title":"Chem Pharm Bull (Tokyo)."},{"key":"B225","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1021\/jm0105676","article-title":"Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake","volume":"45","author":"Rothbard","year":"2002","journal-title":"J Med Chem."},{"key":"B226","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/j.bbamem.2012.06.006","article-title":"Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans","volume":"1818","author":"Amand","year":"2012","journal-title":"Biochim Biophys Acta."},{"key":"B227","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/bip.21641","article-title":"Peptide-glycosaminoglycan cluster formation involving cell penetrating peptides","volume":"95","author":"Rullo","year":"2011","journal-title":"Biopolymers."},{"key":"B228","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12031-016-0861-1","article-title":"The Neuroprotective peptide poly-arginine-12 (R12) reduces cell surface levels of NMDA NR2B receptor subunit in cortical neurons; investigation into the involvement of endocytic mechanisms","volume":"61","author":"MacDougall","year":"2017","journal-title":"J Mol Neurosci."},{"key":"B229","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1242\/jcs.02460","article-title":"Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization","volume":"118","author":"Fotin-Mleczek","year":"2005","journal-title":"J Cell Sci."},{"key":"B230","first-page":"746","article-title":"Agmatine blocked voltage-gated calcium channel in cultured rat hippocampal neurons","volume":"24","author":"Weng","year":"2003","journal-title":"Acta Pharmacol Sin."},{"key":"B231","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1016\/S0021-9258(19)39660-7","article-title":"Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity","volume":"265","author":"Garcia","year":"1990","journal-title":"J Biol Chem."},{"key":"B232","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1073\/pnas.86.14.5631","article-title":"Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methyl-D-aspartate receptor antagonists with neuroprotective properties","volume":"86","author":"Keana","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"B233","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1749-6632.1995.tb16578.x","article-title":"Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate","volume":"765","author":"Goldin","year":"1995","journal-title":"Ann N Y Acad Sci."},{"key":"B234","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1124\/mol.111.074989","article-title":"Elucidating the molecular basis of action of a classic drug: guanidine compounds as inhibitors of voltage-gated potassium channels","volume":"80","author":"Kalia","year":"2011","journal-title":"Mol Pharmacol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.1073\/pnas.1324012111","article-title":"Molecular determinants of Hv1 proton channel inhibition by guanidine derivatives","volume":"111","author":"Hong","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B236","doi-asserted-by":"publisher","first-page":"21759","DOI":"10.1038\/srep21759","article-title":"Arginine side chain interactions and the role of arginine as a gating charge carrier in voltage sensitive ion channels","volume":"6","author":"Armstrong","year":"2016","journal-title":"Sci Rep."},{"key":"B237","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/md15100303","article-title":"Guanidinium toxins and their interactions with voltage-gated sodium ion channels","volume":"15","author":"Dur\u00e1n-Riveroll","year":"2017","journal-title":"Mar Drugs."},{"key":"B238","first-page":"544","article-title":"Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons","volume":"288","author":"Yang","year":"1999","journal-title":"J Pharmacol Exp Ther."},{"key":"B239","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1042\/bj3250289","article-title":"Interactions of polyamines with ion channels","volume":"325","author":"Williams","year":"1997","journal-title":"Biochem J."},{"key":"B240","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF02854898","article-title":"Cell-permeable mitochondrial-targeted peptide antioxidants","volume":"8","author":"Szeto","year":"2006","journal-title":"AAPS J."},{"key":"B241","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.nbd.2018.09.010","article-title":"Mitochondria and neuroprotection in stroke: cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted neuroprotective therapeutics","volume":"121","author":"MacDougall","year":"2019","journal-title":"Neurobiol Dis."},{"key":"B242","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1006\/bbrc.1997.9994","article-title":"Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase?","volume":"234","author":"Wascher","year":"1997","journal-title":"Biochem Biophys Res Commun."},{"key":"B243","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1440-1681.1998.tb02342.x","article-title":"Oxygen radicals and nitric oxide in rat mesenteric ischaemia-reperfusion: modulation by L-arginine and NG-nitro-L-arginine methyl ester","volume":"25","author":"Haklar","year":"1998","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"B244","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/sj.bjp.0701924","article-title":"Comparison of antioxidant activities of aminoguanidine methylguanidine and guanidine by luminol-enhanced chemiluminescence","volume":"124","author":"Yildiz","year":"1998","journal-title":"Br J Pharmacol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1472-8206.1999.tb00358.x","article-title":"Antioxidant properties of aminoguanidine","volume":"13","author":"Courderot-Masuyer","year":"1999","journal-title":"Fundam Clin Pharmacol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.2337\/diabetes.47.7.1114","article-title":"Aminoguanidine inhibits reactive oxygen species formation lipid peroxidation and oxidant-induced apoptosis","volume":"47","author":"Giardino","year":"1998","journal-title":"Diabetes."},{"key":"B247","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/01.ATV.15.3.367","article-title":"Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL","volume":"15","author":"Philis-Tsimikas","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/bbrc.2001.6164","article-title":"Direct antioxidant properties of creatine","volume":"290","author":"Lawler","year":"2002","journal-title":"Biochem Biophys Res Commun."},{"key":"B249","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1124\/mol.61.5.1081","article-title":"Functional and analytical evidence for scavenging of oxygen radicals by L-arginine","volume":"61","author":"Lass","year":"2002","journal-title":"Mol Pharmacol."},{"key":"B250","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1161\/01.CIR.102.21.2629","article-title":"Rapid and efficient vascular transport of arginine polymers inhibits myointimal hyperplasia","volume":"102","author":"Uemura","year":"2000","journal-title":"Circulation."},{"key":"B251","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00210-001-0523-9","article-title":"Antioxidative and myocardial protective effects of L-arginine in oxygen radical-induced injury of isolated perfused rat hearts","volume":"365","author":"Suessenbacher","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B252","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0022-5223(03)00354-4","article-title":"L-Arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats","volume":"126","author":"Kown","year":"2003","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B253","doi-asserted-by":"publisher","first-page":"E969","DOI":"10.3390\/ijerph13100969","article-title":"l-Arginine enhances resistance against oxidative stress and heat stress in Caenorhabditis elegans","volume":"13","author":"Ma","year":"2016","journal-title":"Int J Environ Res Public Health."},{"key":"B254","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.peptides.2014.03.017","article-title":"Identification of multifunctional peptides from human milk","volume":"56","author":"Mandal","year":"2014","journal-title":"Peptides."},{"key":"B255","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.atherosclerosis.2014.06.020","article-title":"Cationic peptides neutralize Ox-LDL prevent its uptake by macrophages and attenuate inflammatory response","volume":"236","author":"Aluganti Narasimhulu","year":"2014","journal-title":"Atherosclerosis."},{"key":"B256","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1177\/0271678X18793266","article-title":"Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia\/reperfusion cerebral injury","volume":"39","author":"Akhmedov","year":"2019","journal-title":"J Cereb Blood Flow Metab."},{"key":"B257","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09168451.2019.1588096","article-title":"Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1","volume":"15","author":"Takemura","year":"2019","journal-title":"Biosci Biotechnol Biochem."},{"key":"B258","doi-asserted-by":"crossref","first-page":"29024","DOI":"10.1016\/S0021-9258(19)62008-9","article-title":"Inhibition of NADPH oxidase activation by synthetic peptides mapping within the carboxyl-terminal domain of small GTP-binding proteins: lack of amino acid sequence specificity and importance of polybasic motif","volume":"269","author":"Joseph","year":"1994","journal-title":"J Biol Chem."},{"key":"B259","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/jcbfm.2015.16","article-title":"Tat-NR2B9c prevents excitotoxic neuronal superoxide production","volume":"35","author":"Chen","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"B260","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1007\/s00018-012-1009-2","article-title":"NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS","volume":"69","author":"Cifuentes-Pagano","year":"2012","journal-title":"Cell Mol Life Sci."},{"key":"B261","doi-asserted-by":"publisher","first-page":"6014","DOI":"10.1073\/pnas.93.12.6014","article-title":"PR-39 a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox","volume":"93","author":"Shi","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"B262","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnins.2015.00023","article-title":"Methylglyoxal the dark side of glycolysis","volume":"9","author":"Allaman","year":"2015","journal-title":"Front Neurosci."},{"key":"B263","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2567.2012.03608.x","article-title":"The role of endothelial cell adhesion molecules P-selectin E-selectin and intercellular adhesion molecule-1 in leucocyte recruitment induced by exogenous methylglyoxal","volume":"137","author":"Su","year":"2012","journal-title":"Immunology."},{"key":"B264","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2016.03.038","article-title":"The protection conferred against ischemia-reperfusion injury in the diabetic brain by N-acetylcysteine is associated with decreased dicarbonyl stress","volume":"96","author":"Wang","year":"2016","journal-title":"Free Radic Biol Med."},{"key":"B265","first-page":"1509","article-title":"Advanced glycation of the Arg-Gly-Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction","volume":"15","author":"McDonald","year":"2009","journal-title":"Mol Vis."},{"key":"B266","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1042\/BST20140018","article-title":"Dicarbonyl proteome and genome damage in metabolic and vascular disease","volume":"42","author":"Rabbani","year":"2014","journal-title":"Biochem Soc Trans."},{"key":"B267","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1474-9726.2008.00371.x","article-title":"Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans","volume":"7","author":"Morcos","year":"2008","journal-title":"Aging Cell."},{"key":"B268","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","article-title":"Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts","volume":"419","author":"Thornalley","year":"2003","journal-title":"Arch Biochem Biophys."},{"key":"B269","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1021\/acs.chemrestox.5b00497","article-title":"Metformin scavenges methylglyoxal to form a novel imidazolinone metabolite in humans","volume":"29","author":"Kinsky","year":"2016","journal-title":"Chem Res Toxicol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1124\/jpet.112.192112","article-title":"Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism","volume":"342","author":"Dhar","year":"2012","journal-title":"J Pharmacol Exp Ther."},{"key":"B271","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.bbadis.2016.12.001","article-title":"A scavenger peptide prevents methylglyoxal induced pain in mice","volume":"1863","author":"Brings","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B272","doi-asserted-by":"publisher","first-page":"36741","DOI":"10.1074\/jbc.M003848200","article-title":"Polyarginines are potent furin inhibitors","volume":"275","author":"Cameron","year":"2000","journal-title":"J Biol Chem."},{"key":"B273","doi-asserted-by":"publisher","first-page":"36788","DOI":"10.1074\/jbc.M400484200","article-title":"Inhibition of furin by polyarginine-containing peptides: nanomolar inhibition by nona-D-arginine","volume":"279","author":"Kacprzak","year":"2004","journal-title":"J Biol Chem."},{"key":"B274","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.bbrc.2004.07.012","article-title":"Cross-inhibition between furin and lethal factor inhibitors","volume":"321","author":"Peinado","year":"2004","journal-title":"Biochem Biophys Res Commun."},{"key":"B275","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1124\/mol.106.027946","article-title":"Short polybasic peptide sequences are potent inhibitors of PC5\/6 and PC7: use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences","volume":"71","author":"Fugere","year":"2007","journal-title":"Mol Pharmacol."},{"key":"B276","doi-asserted-by":"publisher","first-page":"e0130417","DOI":"10.1371\/journal.pone.0130417","article-title":"Cationic cell-penetrating peptides are potent furin inhibitors","volume":"10","author":"Ramos-Molina","year":"2015","journal-title":"PLoS ONE."},{"key":"B277","doi-asserted-by":"publisher","first-page":"6561","DOI":"10.1074\/jbc.M413248200","article-title":"Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins","volume":"280","author":"McMahon","year":"2005","journal-title":"J Biol Chem."},{"key":"B278","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.STR.32.1.168","article-title":"Identification of differentially expressed genes in rat hippocampus after transient global cerebral ischemia using subtractive cDNA cloning based on polymerase chain reaction","volume":"32","author":"Yokota","year":"2001","journal-title":"Stroke."},{"key":"B279","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","article-title":"Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat","volume":"27","author":"Yang","year":"2007","journal-title":"J Cereb Blood Flow Metab."},{"key":"B280","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/ijms12021060","article-title":"FurinDB: a database of 20-residue furin cleavage site motifs substrates and their associated drugs","volume":"12","author":"Tian","year":"2011","journal-title":"Int J Mol Sci."},{"key":"B281","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.brainres.2015.04.024","article-title":"Matrix metalloproteinases as therapeutic targets for stroke","volume":"1623","author":"Yang","year":"2015","journal-title":"Brain Res."},{"key":"B282","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fncel.2016.00056","article-title":"Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke","volume":"10","author":"Turner","year":"2016","journal-title":"Front Cell Neurosci."},{"key":"B283","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1167\/iovs.09-4102","article-title":"Protection of retinal ganglion cells by caspase substrate-binding peptide IQACRG from N-methyl-D-aspartate receptor-mediated excitotoxicity","volume":"51","author":"Seki","year":"2010","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B284","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1046\/j.1432-1327.2000.01364.x","article-title":"Arginine-based structures are specific inhibitors of cathepsin C application of peptide combinatorial libraries","volume":"267","author":"Horn","year":"2000","journal-title":"Eur J Biochem."},{"key":"B285","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1172\/JCI9826","article-title":"Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide","volume":"106","author":"Gao","year":"2000","journal-title":"J Clin Invest."},{"key":"B286","doi-asserted-by":"publisher","first-page":"8663","DOI":"10.1021\/bi034784f","article-title":"Proline- and CARPs constitute a novel class of allosteric inhibitors of proteasome activity","volume":"42","author":"Gaczynska","year":"2003","journal-title":"Biochemistry."},{"key":"B287","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejpb.2008.10.016","article-title":"The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities","volume":"72","author":"Kloss","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"B288","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jmb.2008.09.021","article-title":"Molecular basis for proline- and arginine-rich peptide inhibition of proteasome","volume":"384","author":"Anbanandam","year":"2008","journal-title":"J Mol Biol."},{"key":"B289","doi-asserted-by":"publisher","first-page":"e0143038","DOI":"10.1371\/journal.pone.0143038","article-title":"Interplay between structure and charge as a key to allosteric modulation of human 20S proteasome by the basic fragment of HIV-1 tat protein","volume":"10","author":"Karpowicz","year":"2015","journal-title":"PLoS ONE."},{"key":"B290","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/01.STR.0000126891.93919.4e","article-title":"Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy","volume":"35","author":"Wojcik","year":"2004","journal-title":"Stroke."},{"key":"B291","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1093\/brain\/aws269","article-title":"The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis","volume":"135","author":"Doeppner","year":"2012","journal-title":"Brain."},{"key":"B292","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1007\/s12035-015-9533-3","article-title":"Systemic proteasome inhibition induces sustained post-stroke neurological recovery and neuroprotection via mechanisms involving reversal of peripheral immunosuppression and preservation of blood-brain-barrier integrity","volume":"53","author":"Doeppner","year":"2016","journal-title":"Mol Neurobiol."},{"key":"B293","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1007\/s12035-016-0137-3","article-title":"Ischemic post-conditioning induces post-stroke neuroprotection via Hsp70-mediated proteasome inhibition and facilitates neural progenitor cell transplantation","volume":"54","author":"Doeppner","year":"2017","journal-title":"Mol Neurobiol."},{"key":"B294","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1002\/pmic.200800927","article-title":"Comprehensive proteomic and transcriptomic analysis reveals early induction of a protective anti-oxidative stress response by low-dose proteasome inhibition","volume":"9","author":"Bieler","year":"2009","journal-title":"Proteomics."},{"key":"B295","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/71527","article-title":"PR39 a peptide regulator of angiogenesis","volume":"6","author":"Li","year":"2000","journal-title":"Nat Med."},{"key":"B296","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","article-title":"Role of Nrf2\/HO-1 system in development oxidative stress response and diseases: an evolutionarily conserved mechanism","volume":"73","author":"Loboda","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B297","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1021\/ml300041g","article-title":"Anti-inflammatory effect of a cell-penetrating peptide targeting the Nrf2\/Keap1 interaction","volume":"3","author":"Steel","year":"2012","journal-title":"ACS Med Chem Lett."},{"key":"B298","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.freeradbiomed.2014.09.006","article-title":"Nuclear Nrf2 induction by protein transduction attenuates osteoclastogenesis","volume":"77","author":"Kanzaki","year":"2014","journal-title":"Free Radic Biol Med."},{"key":"B299","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.bbrc.2011.03.046","article-title":"A novel strategy to activate cytoprotective genes in the injured brain","volume":"407","author":"Zhao","year":"2011","journal-title":"Biochem Biophys Res Commun."},{"key":"B300","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.fct.2018.03.029","article-title":"L-Arginine induces antioxidant response to prevent oxidative stress via stimulation of glutathione synthesis and activation of Nrf2 pathway","volume":"115","author":"Liang","year":"2018","journal-title":"Food Chem Toxicol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/mt.2011.82","article-title":"A cell-penetrating peptide suppresses inflammation by inhibiting NF-\u03baB signaling","volume":"19","author":"Wang","year":"2011","journal-title":"Mol Ther."},{"key":"B302","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B303","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1152\/ajpheart.1999.277.3.H1007","article-title":"PR-39 a proline\/arginine-rich antimicrobial peptide prevents postischemic microvascular dysfunction","volume":"277","author":"Korthuis","year":"1999","journal-title":"Am J Physiol."},{"key":"B304","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s13346-015-0230-6","article-title":"TAT cell-penetrating peptide modulates inflammatory response and apoptosis in human lung epithelial cells","volume":"5","author":"Kim","year":"2015","journal-title":"Drug Deliv Transl Res."},{"key":"B305","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.bbalip.2014.01.006","article-title":"Properties of apolipoprotein E derived peptide modulate their lipid-binding capacity and influence their anti-inflammatory function","volume":"184","author":"Nankar","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B306","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s10753-014-9864-7","article-title":"L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils","volume":"37","author":"Sharifov","year":"2014","journal-title":"Inflammation."},{"key":"B307","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.atherosclerosis.2009.07.019","article-title":"Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide Ac-hE18A-NH(2)","volume":"208","author":"Datta","year":"2010","journal-title":"Atherosclerosis."},{"key":"B308","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/exnr.2001.7541","article-title":"Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides","volume":"167","author":"Laskowitz","year":"2001","journal-title":"Exp Neurol."},{"key":"B309","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1111\/febs.13725","article-title":"A new cryptic cationic antimicrobial peptide from human apolipoprotein E with antibacterial activity and immunomodulatory effects on human cells","volume":"283","author":"Pane","year":"2016","journal-title":"FEBS J."},{"key":"B310","doi-asserted-by":"publisher","first-page":"16752","DOI":"10.1074\/jbc.M710530200","article-title":"The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-kappaB activation","volume":"283","author":"Singh","year":"2008","journal-title":"J Biol Chem."},{"key":"B311","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1074\/jbc.M110.176719","article-title":"The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling proinflammatory cytokine expression and disease activity in murine models of colitis","volume":"286","author":"Singh","year":"2011","journal-title":"J Biol Chem."},{"key":"B312","doi-asserted-by":"publisher","first-page":"27391","DOI":"10.3390\/ijms161126025","article-title":"Cell-penetrating ability of peptide hormones: key role of glycosaminoglycans clustering","volume":"16","author":"Neree","year":"2015","journal-title":"Int J Mol Sci."},{"key":"B313","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0006-8993(96)00920-1","article-title":"Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity","volume":"741","author":"Morio","year":"1996","journal-title":"Brain Res."},{"key":"B314","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1196\/annals.1317.074","article-title":"Neuroprotective effect of PACAP against kainic acid-induced neurotoxicity in rat retina","volume":"1070","author":"Seki","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B315","doi-asserted-by":"publisher","first-page":"E675","DOI":"10.3390\/ijms18030675","article-title":"Passage through the ocular barriers and beneficial effects in retinal ischemia of topical application of PACAP1\u201338 in rodents","volume":"18","author":"Werling","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B316","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1161\/01.STR.31.6.1411","article-title":"Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat","volume":"31","author":"Reglodi","year":"2000","journal-title":"Stroke."},{"key":"B317","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12031-012-9818-1","article-title":"Multimodal neuroprotection induced by PACAP38 in oxygen-glucose deprivation and middle cerebral artery occlusion stroke models","volume":"48","author":"Lazarovici","year":"2012","journal-title":"J Mol Neurosci."},{"key":"B318","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1089\/neu.2011.2244","article-title":"Exogenous administration of PACAP alleviates traumatic brain injury in rats through a mechanism involving the TLR4\/MyD88\/NF-\u03baB pathway","volume":"29","author":"Mao","year":"2012","journal-title":"J Neurotrauma."},{"key":"B319","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.brainres.2004.08.017","article-title":"Neuropeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia","volume":"1026","author":"Suk","year":"2004","journal-title":"Brain Res."},{"key":"B320","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/intimm\/dxl107","article-title":"The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands","volume":"18","author":"Kandler","year":"2006","journal-title":"Int Immunol."},{"key":"B321","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.4049\/jimmunol.174.9.5846","article-title":"Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes","volume":"174","author":"Yoo","year":"2005","journal-title":"J Immunol."},{"key":"B322","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.molimm.2013.08.011","article-title":"Human cathelicidin LL-37-derived peptide IG-19 confers protection in a murine model of collagen-induced arthritis","volume":"57","author":"Chow","year":"2014","journal-title":"Mol Immunol."},{"key":"B323","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.peptides.2018.01.010","article-title":"Induction by innate defence regulator peptide 1018 of pro-angiogenic molecules and endothelial cell migration in a high glucose environment","volume":"101","author":"Marin-Luevano","year":"2018","journal-title":"Peptides."},{"key":"B324","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/art.27198","article-title":"Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis","volume":"62","author":"Scatizzi","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B325","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.exer.2018.07.020","article-title":"A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis","volume":"177","author":"Ahmed","year":"2018","journal-title":"Exp Eye Res."},{"key":"B326","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/ICO.0b013e3181ca3a69","article-title":"Nona-D-arginine amide suppresses corneal cytokines in Pseudomonas aeruginosa keratitis","volume":"29","author":"Karicherla","year":"2010","journal-title":"Cornea."},{"key":"B327","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.2147\/IJN.S90014","article-title":"Identification of a cell-penetrating peptide domain from human beta-defensin 3 and characterization of its anti-inflammatory activity","volume":"10","author":"Lee","year":"2015","journal-title":"Int J Nanomedicine."},{"key":"B328","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000463049","article-title":"Complement C5a receptor antagonism by protamine and poly-L-Arg on human leukocytes","volume":"5","author":"Olsen","year":"1988","journal-title":"Complement."},{"key":"B329","doi-asserted-by":"publisher","first-page":"8193932","DOI":"10.1155\/2017\/8193932","article-title":"The controversial C5a receptor C5aR2: its role in health and disease","volume":"2017","author":"Zhang","year":"2017","journal-title":"J Immunol Res."},{"key":"B330","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/smll.201302887","article-title":"Polyarginine induces an antitumor immune response through binding to toll-like receptor 4","volume":"10","author":"Yang","year":"2014","journal-title":"Small."},{"key":"B331","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1189\/jlb.1012497","article-title":"The innate defense regulator peptides IDR-HH2 IDR-1002 and IDR-1018 modulate human neutrophil functions","volume":"94","author":"Niyonsaba","year":"2013","journal-title":"J Leukoc Biol."},{"key":"B332","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.bbagen.2017.05.017","article-title":"Bioactivity of the putative apelin proprotein expands the repertoire of apelin receptor ligands","volume":"1861","author":"Shin","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj."},{"key":"B333","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0042-6822(03)00185-5","article-title":"Binding of ALX40\u20134C to APJ a CNS-based receptor inhibits its utilization as a co-receptor by HIV-1","volume":"312","author":"Zhou","year":"2003","journal-title":"Virology."},{"key":"B334","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0042-6822(03)00638-X","article-title":"The N-terminal domain of APJ a CNS-based coreceptor for HIV-1 is essential for its receptor function and coreceptor activity","volume":"317","author":"Zhou","year":"2003","journal-title":"Virology."},{"key":"B335","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1096\/fj.201601074R","article-title":"Protamine is an antagonist of apelin receptor and its activity is reversed by heparin","volume":"31","author":"Le Gonidec","year":"2017","journal-title":"FASEB J."},{"key":"B336","doi-asserted-by":"publisher","first-page":"18317","DOI":"10.1074\/jbc.M600606200","article-title":"The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments","volume":"281","author":"Masri","year":"2006","journal-title":"J Biol Chem."},{"key":"B337","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.cellsig.2011.12.012","article-title":"Heterodimerization of human apelin and kappa opioid receptors: roles in signal transduction","volume":"24","author":"Li","year":"2012","journal-title":"Cell Signal."},{"key":"B338","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/abbs\/gmx035","article-title":"Novel pathogenesis: regulation of apoptosis by Apelin\/APJ system","volume":"49","author":"Liu","year":"2017","journal-title":"Acta Biochim Biophys Sin (Shanghai)."},{"key":"B339","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1530\/JOE-13-0227","article-title":"The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis","volume":"219","author":"O'Carroll","year":"2013","journal-title":"J Endocrinol."},{"key":"B340","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fphys.2015.00115","article-title":"Apelin and energy metabolism","volume":"6","author":"Bertrand","year":"2015","journal-title":"Front Physiol."},{"key":"B341","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.yexcr.2010.02.005","article-title":"Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons","volume":"316","author":"Zeng","year":"2010","journal-title":"Exp Cell Res."},{"key":"B342","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2017.00001","article-title":"Temporal expression of apelin\/apelin receptor in ischemic stroke and its therapeutic potential","volume":"10","author":"Wu","year":"2017","journal-title":"Front Mol Neurosci."},{"key":"B343","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-015-0521-6","article-title":"Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart","volume":"111","author":"Perj\u00e9s","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"B344","doi-asserted-by":"publisher","first-page":"e92597","DOI":"10.1371\/journal.pone.0092597","article-title":"Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase\/Akt\/mTOR pathway","volume":"9","author":"Tomioka","year":"2014","journal-title":"PLoS ONE."},{"key":"B345","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.4049\/jimmunol.172.6.3758","article-title":"The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes","volume":"172","author":"Bowdish","year":"2004","journal-title":"J Immunol."},{"key":"B346","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2012.11.009","article-title":"A comprehensive summary of LL-37 the factotum human cathelicidin peptide","volume":"280","author":"Vandamme","year":"2012","journal-title":"Cell Immunol."},{"key":"B347","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1016\/S0021-9258(19)47304-3","article-title":"Protamine enhances epidermal growth factor (EGF)-stimulated mitogenesis by increasing cell surface EGF receptor number. Implications for existence of cryptic EGF receptors","volume":"264","author":"Lokeshwar","year":"1989","journal-title":"J Biol Chem."},{"key":"B348","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1042\/bj2810107","article-title":"Alteration of the kinetic properties of the epidermal growth factor receptor tyrosine kinase by basic proteins","volume":"281","author":"Hubler","year":"1992","journal-title":"Biochem J."},{"key":"B349","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1021\/bi047528r","article-title":"Role of arginine in the stabilization of proteins against aggregation","volume":"44","author":"Baynes","year":"2005","journal-title":"Biochemistry."},{"key":"B350","doi-asserted-by":"publisher","first-page":"13426","DOI":"10.1021\/jp108399g","article-title":"Interaction of arginine with proteins and the mechanism by which it inhibits aggregation","volume":"114","author":"Shukla","year":"2010","journal-title":"J Phys Chem B."},{"key":"B351","doi-asserted-by":"publisher","first-page":"8898","DOI":"10.1021\/bi050225s","article-title":"Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context","volume":"44","author":"Gibson","year":"2005","journal-title":"Biochemistry."},{"key":"B352","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neurobiolaging.2008.03.023","article-title":"Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity","volume":"31","author":"Taddei","year":"2010","journal-title":"Neurobiol Aging."},{"key":"B353","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1271\/bbb.110198","article-title":"Identification of novel short peptide inhibitors of soluble 37\/48 kDa oligomers of amyloid \u03b242","volume":"75","author":"Kawasaki","year":"2011","journal-title":"Biosci Biotechnol Biochem."},{"key":"B354","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1271\/bbb.110879","article-title":"Inhibition of aggregation of amyloid \u03b242 by arginine-containing small compounds","volume":"76","author":"Kawasaki","year":"2012","journal-title":"Biosci Biotechnol Biochem."},{"key":"B355","doi-asserted-by":"publisher","first-page":"e54769","DOI":"10.1371\/annotation\/57e0a947-8600-4658-b04c-cf7a45c8bd8d","article-title":"A novel retro-inverso peptide inhibitor reduces amyloid deposition oxidation and inflammation and stimulates neurogenesis in the APPswe\/PS1\u0394E9 mouse model of Alzheimer's disease","volume":"8","author":"Parthsarathy","year":"2013","journal-title":"PLoS ONE."},{"key":"B356","doi-asserted-by":"publisher","first-page":"703","DOI":"10.15252\/emmm.201606666","article-title":"An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice","volume":"9","author":"Cheng","year":"2017","journal-title":"EMBO Mol Med."},{"key":"B357","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4236\/aad.2018.74011","article-title":"Subcutaneous sustained-release of poly-arginine ameliorates cognitive impairment in a transgenic mouse model of Alzheimer's disease","volume":"7","author":"Fonar","year":"2018","journal-title":"Adv Alzheimer's Dis."},{"key":"B358","doi-asserted-by":"publisher","first-page":"e23024","DOI":"10.1002\/bip.23024","article-title":"Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine","volume":"107","author":"Nadimidla","year":"2017","journal-title":"Biopolymers."},{"key":"B359","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1146\/annurev-pharmtox-010715-103042","article-title":"The emerging role of spinal dynorphin in chronic pain: a therapeutic perspective","volume":"56","author":"Podvin","year":"2016","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"B360","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0304-3940(98)00466-2","article-title":"Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells","volume":"250","author":"Reis","year":"1998","journal-title":"Neurosci Lett."},{"key":"B361","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1073\/pnas.88.14.6368","article-title":"Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures","volume":"88","author":"Dawson","year":"1991","journal-title":"Proc Natl Acad Sci USA."},{"key":"B362","doi-asserted-by":"publisher","first-page":"318087","DOI":"10.1155\/2012\/318087","article-title":"Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges","volume":"2012","author":"V\u00edte\u010dek","year":"2012","journal-title":"Mediators Inflamm."},{"key":"B363","unstructured":"Field Randomization of NA-1 Therapy in Early Responders (FRONTIER)"},{"key":"B364","unstructured":"Safety and Efficacy of NA-1 in Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1)"},{"key":"B365","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/jcph.853","article-title":"Phase 1 randomized, double-blind, placebo-controlled study to determine the safety, tolerability, and pharmacokinetics of a single escalating dose and repeated doses of CN-105 in healthy adult subjects","volume":"57","author":"Guptill","year":"2017","journal-title":"J Clin Pharmacol."},{"key":"B366","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1474-4422(12)70225-9","article-title":"ENACT trial investigators. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"11","author":"Hill","year":"2012","journal-title":"Lancet Neurol."},{"key":"B367","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/08892220151126508","article-title":"Safe use of the CXCR4 inhibitor ALX40\u20134C in humans","volume":"17","author":"Doranz","year":"2001","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B368","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/17425255.2016.1194395","article-title":"The toxicology of heparin reversal with protamine: past, present and future","volume":"12","author":"Sokolowska","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"B369","doi-asserted-by":"publisher","first-page":"E2237","DOI":"10.3390\/molecules24122237","article-title":"Do we need anti-prion compounds to treat Alzheimer's disease?","volume":"24","author":"Willbold","year":"2019","journal-title":"Molecules"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00108\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T20:22:01Z","timestamp":1614543721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00108\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":369,"alternative-id":["10.3389\/fneur.2020.00108"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00108","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"article-number":"108"}}